Breaking News Instant updates and real-time market news.

GME

GameStop

$13.84

0.16 (1.17%)

, ANF

Abercrombie & Fitch

$28.11

0.01 (0.04%)

07:30
04/12/18
04/12
07:30
04/12/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Wednesday in GameStop (GME), Abercrombie & Fitch (ANF), and Healthcare Services (HCSG).

GME

GameStop

$13.84

0.16 (1.17%)

ANF

Abercrombie & Fitch

$28.11

0.01 (0.04%)

HCSG

Healthcare Services

$41.88

0.24 (0.58%)

  • 25

    Apr

  • 12

    Jun

GME GameStop
$13.84

0.16 (1.17%)

04/03/18
04/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Commercial Metals (CMC) downgraded to Neutral from Buy at Citi analyst Alexander Hacking saying multiple new rebar projects announced in recent months will offset the benefit of lower imports. 2. GameStop (GME) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba saying while the company's core video game business improved in fiscal 2017, its Technology Brands "dramatically underperformed," and collectibles sales missed expectations. 3. Manpower (MAN) downgraded to Underweight from Equal Weight at Barclays with analyst Manav Patnaik saying he believes good news is reflected in the current valuation and he expects Manpower to underperform its Temp Staffing peers. 4. Cancer Genetics (CGIX) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's "disappointing" fourth quarter revenues and what he views as a lack of strategic direction at the company. 5. Weatherford (WFT) downgraded to Neutral from Overweight at Piper Jaffray with analyst Bill Herbert saying the company's turnaround is taking longer than expected, and its balance sheet is "prodigiously heavy." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/18
LOOP
04/03/18
DOWNGRADE
Target $14
LOOP
Hold
GameStop downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Anthony Chukumba downgraded GameStop to Hold and cut his price target for the shares to $14 from $26. The shares closed yesterday up 20c to $12.82. While the company's core video game business improved in fiscal 2017, its Technology Brands "dramatically underperformed," and collectibles sales missed expectations, Chukumba tells investors in a research note. The analyst is concerned with GameStop's declining sales and profitability in pre-owned and value video game products and believes management's reluctance to repurchase stock "sends a worrisome signal to investors." He sees a "lack of positive catalysts on the horizon" for the shares.
03/29/18
03/29/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GameStop (GME) downgraded to Underperform from Neutral at BofA/Merrill by analyst Curtis nagle, who said he no longer believes GameStop's non-gaming segments will be sources of growth or earnings over the next few years and cut estimates well below the Street for 2018. He expects increased earnings pressure in 2019 and beyond as strong sales from the Nintendo Switch and Collectibles expansion, and lower tax rate are lapped. 2. Cloud Peak Energy (CLD) downgraded to Underweight from Neutral at JPMorgan by analyst John Bridges, saying he sees higher risk for the company from lower natural gas prices as production ramps up from the Permian basin. He also believes Cloud Peak has a "lesser diversified production profile" with exposure to thermal coal only. 3. Starbucks (SBUX) downgraded to Neutral from Outperform at Wedbush. 4. ViaSat (VSAT) downgraded to Underweight from Equal Weight at Barclays by analyst Mathieu Robilliard. The analyst sees see continued risk for oversupply in the satellite industry. The sector stock price performance has started to reflect these concerns, apart from ViaSat which has outperformed peers, Robilliard said, adding that he believes the current stock price reflects assumptions that are too optimistic. 5. DiamondRock (DRH) downgraded to Underperform from Neutral at Boenning & Scattergood by analyst Floris van Dijkum following share strength related to the LaSalle Hotel (LHO) bid announcement as he believes shares are not overly discounted relative to hotel peers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/18
BARD
03/29/18
NO CHANGE
Target $18
BARD
Outperform
GameStop price target lowered to $18 from $23 at Baird
Baird analyst Colin Sebastian lowered his price target on GameStop to $18 from $23 following Q4 results. The analyst said the results reflect the Switch hardware revenues during the holiday season and strong contributions from new software. He noted management announced a pivot toward optimizing existing stores and operations albeit on lower margins. The new strategy is reflected in his price target reduction. Sebastian maintained his Outperform rating on GameStop shares.
ANF Abercrombie & Fitch
$28.11

0.01 (0.04%)

03/08/18
BARD
03/08/18
NO CHANGE
Target $27
BARD
Neutral
Abercrombie & Fitch results suggest 'turning a corner,' says Baird
Baird analyst Mark Altschwager noted Abercrombie & Fitch reported better than expected Q4 results, suggesting the company has turned a corner. The analyst also noted its raised guidance, its expense control, and continued investments. Altschwager maintained his Neutral rating and raised his price target to $27 from $21 on Abercrombie & Fitch shares.
03/07/18
DBAB
03/07/18
NO CHANGE
Target $17
DBAB
Sell
Deutsche Bank ups Abercrombie target to $17, reiterates Sell rating
Deutsche Bank analyst Tiffany Kanaga raised her price target for Abercrombie & Fitch to $17 from $14 following the company's Q4 results but reiterates a Sell rating on the name. While the analyst expects positive total company comps to carry forward through the first half of 2018 before "very tough compares" in the second half, she expects EBITDA dollars to remain down mid- to high-teens in 2018 and 2019. Kanaga is "highly skeptical" of Abercrombie's ability to stabilize margin against "what is still a competitive mall-based apparel backdrop."
01/24/18
RBCM
01/24/18
NO CHANGE
Target $24
RBCM
Sector Perform
Abercrombie & Fitch price target raised to $24 from $16 at RBC Capital
RBC Capital analyst Brian Tunick raised his price target on Abercrombie & Fitch to $24 after the company's strong holiday sales update. Tunick keeps his Sector Perform rating, noting the risk-reward profile is less compelling at the current price point despite the anticipated positive catalysts at the upcoming April analyst day.
01/23/18
BMOC
01/23/18
NO CHANGE
Target $22
BMOC
Market Perform
Abercrombie & Fitch price target raised to $22 from $16 at BMO Capital
BMO Capital analyst John Morris raised his price target on Abercrombie & Fitch to $22 after the company raised its Q4 comps outlook. Morris notes that the company's plans for an investor day in late April suggest that the management is comfortable enough to meet with shareholders. The analyst keeps his Market Perform rating on Abercrombie & Fitch, saying the stock is fairly valued, with "a lot of work ahead" in right-sizing the company.
HCSG Healthcare Services
$41.88

0.24 (0.58%)

02/07/18
BARD
02/07/18
DOWNGRADE
BARD
Neutral
Healthcare Services downgraded to Neutral from Outperform at Baird
02/07/18
BARD
02/07/18
DOWNGRADE
Target $50
BARD
Neutral
Healthcare Services downgraded to Neutral at Baird
As previously reported, Baird analyst Andrew Wittmann downgraded Healthcare Services to Neutral from Outperform following in-line Q4 earnings. The analyst sees subdued revenue growth and a period of digestion as management turns its focus to execution. Wittmann believes Healthcare Services shares are fully valued at current levels and lowered his price target to on the stock to $50 from $58.
02/07/18
SIDC
02/07/18
UPGRADE
SIDC
Buy
Healthcare Services upgraded to Buy from Neutral at Sidoti
03/05/18
03/05/18
NO CHANGE

Pacific Square raises risk rating on Healthcare Services
Pacific Square Research increased its risk rating on Healthcare Services Group to an "orange flag" from a "yellow flag," sources tell The Fly. The firm noted that the company's earnings and gross margin would have been considerably lower this quarter without the reversing of an insurance reserve.

TODAY'S FREE FLY STORIES

CTXS

Citrix

$96.54

0.04 (0.04%)

05:16
04/26/18
04/26
05:16
04/26/18
05:16
Recommendations
Citrix analyst commentary  »

Citrix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 08

    May

  • 09

    May

AMD

AMD

$9.72

-0.37 (-3.67%)

05:13
04/26/18
04/26
05:13
04/26/18
05:13
Recommendations
AMD analyst commentary  »

AMD could see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

EBAY

eBay

$40.98

-0.2 (-0.49%)

05:09
04/26/18
04/26
05:09
04/26/18
05:09
Recommendations
eBay analyst commentary  »

eBay GMV growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

Trivago

$4.71

-1.65 (-25.94%)

05:01
04/26/18
04/26
05:01
04/26/18
05:01
Downgrade
Trivago rating change  »

Trivago downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPR

HighPoint Resources

$6.65

0.14 (2.15%)

04:58
04/26/18
04/26
04:58
04/26/18
04:58
Initiation
HighPoint Resources initiated  »

HighPoint Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

AVY

Avery Dennison

$106.68

1.195 (1.13%)

04:57
04/26/18
04/26
04:57
04/26/18
04:57
Upgrade
Avery Dennison rating change  »

Avery Dennison upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 4/21 Jobless…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/25 Fed Balance…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders to be reported at 08:30 »

March Durable Goods…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

March Durable Goods…

WYN

Wyndham

$117.67

1.83 (1.58%)

, LQ

La Quinta

$19.70

0.08 (0.41%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
La Quinta to host special shareholder meeting »

Special Shareholder…

WYN

Wyndham

$117.67

1.83 (1.58%)

LQ

La Quinta

$19.70

0.08 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 02

    May

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/16 Money Supply…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

March International Trade…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 »

March Wholesale…

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/20 EIA Natural…

SMMT

Summit Therapeutics

$13.66

0.13 (0.96%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Summit Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

ABBV

AbbVie

$91.91

0.57 (0.62%)

, ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
American Academy of Neurology to hold annual meeting »

2018 Annual Meeting of…

ABBV

AbbVie

$91.91

0.57 (0.62%)

ACOR

Acorda Therapeutics

$22.95

-0.15 (-0.65%)

ALXN

Alexion

$106.07

-0.37 (-0.35%)

AKCA

Akcea Therapeutics

$26.85

0.02 (0.07%)

RHHBY

Roche

TEVA

Teva

$17.27

-0.28 (-1.60%)

UBS

UBS

$16.78

-0.095 (-0.56%)

MDT

Medtronic

$79.47

0.12 (0.15%)

MCK

McKesson

$151.70

2.76 (1.85%)

NVTA

Invitae

$5.53

-0.15 (-2.64%)

IONS

Ionis Pharmaceuticals

$43.98

-1.35 (-2.98%)

IPXL

Impax

$19.25

-0.65 (-3.27%)

DNA

Bought by RHHBY

DGX

Quest Diagnostics

$101.17

1.42 (1.42%)

ESALY

Eisai

DEPO

Depomed

$6.66

-0.17 (-2.49%)

CPRX

Catalyst Pharmaceuticals

$2.64

0.04 (1.54%)

BSX

Boston Scientific

$29.44

1.01 (3.55%)

BMRN

BioMarin

$81.41

0.33 (0.41%)

MYL

Mylan

$38.93

-1.32 (-3.28%)

NBIX

Neurocrine

$78.13

-0.3 (-0.38%)

NVS

Novartis

$76.42

-0.58 (-0.75%)

PFE

Pfizer

$36.69

-0.36 (-0.97%)

RARX

RA Pharmaceuticals

$5.76

-0.2 (-3.36%)

SNY

Sanofi

$40.11

0.335 (0.84%)

SYK

Stryker

$165.44

0.77 (0.47%)

SUPN

Supernus

$47.30

0.55 (1.18%)

LLY

Eli Lilly

$81.17

1.08 (1.35%)

BAYRY

Bayer

AMGN

Amgen

$174.83

2.92 (1.70%)

ALNY

Alnylam

$94.35

-0.34 (-0.36%)

BIIB

Biogen

$269.47

7.45 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 28

    Apr

  • 30

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 04

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 28

    May

  • 30

    May

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 16

    Jun

  • 06

    Jul

  • 11

    Aug

  • 12

    Sep

  • 05

    Oct

  • 20

    Oct

  • 13

    Nov

  • 28

    Jan

SCPH

scPharmaceuticals

$9.92

-0.1 (-1.00%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
scPharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    Jun

ALNA

Allena Pharmaceuticals

$14.77

0.845 (6.07%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RIO

Rio Tinto

$55.24

-0.44 (-0.79%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Rio Tinto management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

04:55
04/26/18
04/26
04:55
04/26/18
04:55
General news
Breaking General news story  »

Week of 4/22 Bloomberg…

SPNE

SeaSpine

$11.05

-0.11 (-0.99%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
SeaSpine management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 03

    May

PYPL

PayPal

$74.00

-1.29 (-1.71%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
PayPal has a conference call hosted by JPMorgan »

JPMorgan Analyst Huang…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 22

    May

  • 23

    May

  • 12

    Jun

NFLX

Netflix

$305.73

-1.51 (-0.49%)

04:55
04/26/18
04/26
04:55
04/26/18
04:55
Conference/Events
Netflix management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.